Terkko Navigator / Lancet Infectious Diseases

Bacteriophages: it's a medicine, Jim, but not as we know it

Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial

Defending against a difficult clostridioides with a vaccine

Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial

Associations between phone mobility data and COVID-19 cases

Bats and Viruses: Current Research and Future Trends, Eugenia Corrales-Aguilar, Martin Schwemmle (Eds.). Caister Academic Press Ltd (2020), 230, £159·00, ISBN: 978-1912530144

Peter Byass

Intention to vaccinate against COVID-19 in Australia

Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial

SARS-CoV-2 transmission via speech-generated respiratory droplets

Correction to Lancet Infect Dis 2020; published online Aug 25. https://doi.org/10.1016/S1473-3099(20)30289-9

Correction to Lancet Infect Dis 2020; published online Aug 25. https://doi.org/10.1016/S1473-3099(20)30577-6

Curing COVID-19

Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals

Electronic health record data for antimicrobial prescribing

Quantification and interpretation of attributable mortality in core clinical infectious disease journals

Group B streptococcus vaccines: one step further

Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial

Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial

Assessing reduced-dose pneumococcal vaccine schedules in South Africa

Evidence for action: a One Health learning platform on interventions to tackle antimicrobial resistance

Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study

COVID-19 and multisystem inflammatory syndrome in children and adolescents

Good news from WHO on prevention of peripartum hepatitis B transmission

Correction to Lancet Infect Dis 2020; published online Aug 3. https://doi.org/10.1016/S1473-3099(20)30589-2

Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis

Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis

Correction to Lancet Infect Dis 2020; 20: e192–97

Inclusion of pregnant women in COVID-19 vaccine development

Evolving ethics of COVID-19 challenge trials

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics

COVID-19 pandemic more than a century after the Spanish flu

Dental procedure aerosols and COVID-19

A need for open public data standards and sharing in light of COVID-19

SARS-CoV-2 epidemic in African countries—are we losing perspective?

Elimination of COVID-19: what would it look like and is it possible?

STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studies

Staphylococcus aureus bacteraemia: does duration matter?

Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study

SeroTracker: a global SARS-CoV-2 seroprevalence dashboard

Excess mortality from COVID-19 in an English sentinel network population

Correction to Lancet Infect Dis 2020; published online July 2. https://doi.org/10.1016/S1473-3099(20)30527-2

Using serological data to understand unobserved SARS-CoV-2 risk in health-care settings

Risk of COVID-19 in health-care workers in Denmark: an observational cohort study

Lung fibrosis: an undervalued finding in COVID-19 pathological series

Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data

Global increases in antibiotic consumption: a concerning trend for WHO targets

Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential

Harmonisation preserves research resources

Monitoring approaches for health-care workers during the COVID-19 pandemic